Consultation services:

Using strong information integration and analysis capabilities to provide strategic and operational solutions in the whole life cycle of product development from pre-clinical to post-marketing.

• Planning and construction of nuclear medicine department

• Consultation on registration and clinical trial regulations

• GCP/GLP consultation and audit

• Corrective and Preventive Actions (CAPA)

• GCP quality system construction

• Multinational declaration/clinical development strategies such as China and the United States

• Evaluation and consultation of new drug research and development